12236
C.-E. Yeom et al. / Tetrahedron 61 (2005) 12227–12237
3.79 (br, 1H), 3.65 (m, 2H), 3.26–3.24 (m, 2H), 1.69–1.66
(m, 2H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) d 157.4,
79.8, 59.6, 37.5, 33.0, 28.7.
Acknowledgements
Generous financial support from the Korea Research Fund
(2004-015-C00273) is gratefully acknowledged.
4.5.14. N-[(20-Trimethylsilylethyl)oxy]-3-amino-1-pro-
panol (Table 3, entry 7). (Eluted with n-hexane/EtOAcZ
1:1, colorless oil); H NMR (300 MHz, CDCl3) d 5.14 (br,
1
1H), 4.11 (t, JZ8.4 Hz, 2H), 3.63 (m, 2H), 3.31–3.25 (m,
3H), 2.42 (br, 1H), 1.66 (quint, JZ6.6 Hz, 2H), 0.94 (t, JZ
8.4 Hz, 2H), 0.00 (s, 9H); 13C NMR (75 MHz, CDCl3) d
158.2, 63.6, 59.7, 37.9, 33.0, 18.1, K1.1; HRMS (CI) Calcd
for C9H22NO3Si [MCH]C, 220.1369, found 220.1371.
References and notes
1. (a) Greene, T. W.; Wuts, P. G. M. Protective Groups in
Organic Synthesis, 3rd ed.; Wiley: New York, 1999. (b)
Kocienski, P. J. Protecting groups; George Thieme Verlag:
New York, 1994. (c) Corey, E. J.; Venkateswarlu, A. J. Am.
Chem. Soc. 1972, 94, 6190.
4.5.15. (E)-4-(Benzyloxy)-2-buten-1-ol (Table 3, entry
8).23k (Eluted with n-hexane/EtOAcZ2:1, colorless oil); 1H
NMR (300 MHz, CDCl3) d 7.37–7.26 (m, 5H), 5.81–5.66
(m, 2H), 4.54 (s, 2H), 4.28–4.27 (m, 2H), 4.14–4.12 (m,
2H), 2.24 (br, 1H); 13C NMR (75 MHz, CDCl3) d 138.0,
132.3, 128.3, 127.7, 127.5, 72.6, 70.3, 62.7.
2. For reviews, see: Lalonde, M.; Chan, T. H. Synthesis 1985,
817. (b) Nelson, T. D.; Crouch, R. D. Synthesis 1996, 1031.
3. Ranu, B. C.; Jana, U.; Majee, A. Tetrahedron Lett. 1985, 26, 681.
4. (a) Blass, B. E.; Harris, C. L.; Portlock, D. E. Tetrahedron Lett.
2001, 42, 1611. (b) Kremsky, J. N.; Sinha, N. D. Bioorg. Med.
Chem. Lett. 1994, 4, 2171.
4.5.16. 4-(Benzyloxy)-2-butyn-1-ol (Table 3, entry 9).23l
(Eluted with n-hexane/EtOAcZ2:1, colorless oil); 1H NMR
(300 MHz, CDCl3) d 7.37–7.27 (m, 5H), 4.61 (s, 2H), 4.23 (d,
2H), 4.09 (m, 2H), 1.68 (br, 1H); 13C NMR (75 MHz, CDCl3)
d 137.4, 128.4, 128.1, 127.9, 86.3, 81.7, 71.6, 71.4, 57.4.
5. (a) Crouch, R. D. Tetrahedron 2004, 60, 5833. (b) Grieco,
P. A.; Markworth, C. J. T. Tetrahedron Lett. 1999, 40, 665. (c)
Gopinath, R.; Patel, B. K. Org. Lett. 2000, 2, 4177. (d) Khan,
A. T.; Mondal, E. Synlett 2003, 694. (e) Oyama, K.; Kondo, T.
Org. Lett. 2003, 5, 209. (f) Lipshutz, B. H.; Keith, J.
Tetrahedron Lett. 1998, 39, 2495. (g) Crouch, R. D.;
Romany, C. A.; Kreshock, A. C.; Menconi, K. A.; Zile, J. L.
Tetrahedron Lett. 2004, 45, 1279. (h) Fenteany, G.; Ankala,
S. V. Tetrahedron Lett. 2002, 43, 4729. (i) Rotulo-Sims, D.;
Prunet, J. Org. Lett. 2002, 4, 4701. (j) Crouch, R. D.; Polizzi,
J. M.; Cleiman, R. A.; Yi, C. J.; Romany, C. A. Tetrahedron
Lett. 2002, 43, 7151. (k) Crouch, R. D.; Stieff, M.; Frie, J. L.;
Cadwallader, A. B.; Bevis, D. C. Tetrahedron Lett. 1999, 40,
3133. (l) Bartoli, G.; Bosco, M.; Marcantoni, E.; Sambri, L.;
Torregiani, E. Synlett 1998, 209. (m) Farras, J.; Serra, C.;
Vilarrasa, J. Tetrahedron Lett. 1998, 39, 327.
4.5.17. 6-(Benzyloxy)-1,2-hexanediol (Table 3, entry
10).23m (Eluted with n-hexane/EtOAcZ5:1, colorless oil);
1H NMR (300 MHz, CDCl3) d 7.37–7.25 (m, 5H), 4.48 (s,
2H), 3.76–3.31 (m, 5H), 3.24 (br, 2H), 1.75–1.38 (m, 6H);
13C NMR (75 MHz, CDCl3) d 138.0, 129.4, 128.8, 128.6,
72.6, 70.6, 67.2, 33.4, 30.0, 26.2, 22.6.
4.5.18. 2-[40-(Triethylsilyloxy)phenyl]ethanol (Table 4,
entry 1).22d (Eluted with n-hexane/EtOAcZ6:1, colorless
oil); H NMR (300 MHz, CDCl3) d 7.06–7.04 (m, 2H),
1
6.81–6.77 (m, 2H), 3.76 (t, JZ6.6 Hz, 2H), 2.76 (t, JZ
6.6 Hz, 2H), 2.04 (br, 1H), 1.02–0.97 (m, 9H), 0.77–0.69
(m, 6H); 13C NMR (75 MHz, CDCl3) d 154.5, 131.5, 130.3,
120.4, 64.1, 38.8, 7.0, 5.4.
6. (a) Sabitha, G.; Syamala, M.; Yadav, J. S. Org. Lett. 1999, 1,
1701. (b) Wang, M.; Li, C.; Yin, D.; Liang, X. Tetrahedron
Lett. 2002, 43, 8727. (c) Wu, Y.; Huang, J.; Shen, X.; Tang, C.;
Li, L. Org. Lett. 2002, 4, 2141. (d) Paterson, I.; Cowden, C. J.;
Rahn, V. S.; Woodrow, M. D. Synlett 1998, 915.
4.5.19. 4-(tert-Butyldimethylsilyloxy)benzyl alcohol
(Table 4, entry 2).19c (Eluted with n-hexane/EtOAcZ6:1,
colorless oil); 1H NMR (300 MHz, CDCl3) d 7.23 (m, 2H),
6.84 (m, 2H), 4.60 (s, 2H), 1.74 (br, 1H), 0.98 (s, 9H), 0.18
(s, 6H); 13C NMR (75 MHz, CDCl3) d 155.7, 132.3, 129.9,
120.3, 64.6, 25.6, 18.4, K4.0.
7. (a) Sajiki, H.; Ikawa, T.; Hattori, K.; Hirota, K. Chem.
Commun. 2003, 654. (b) Ikawa, T.; Hattori, K.; Sajiki, H.;
Hirota, K. Tetrahedron 2004, 60, 6901. (c) Kim, S.; Jacobo,
S. M.; Chang, C. T.; Bellone, S.; Powell, W. S.; Rokach, J.
Tetrahedron Lett. 2004, 45, 1973.
8. (a) Olofson, R. A.; Martz, J. T.; Senet, J.-P.; Piteau, M.;
Malfroot, T. J. Org Chem. 1984, 49, 2081. (b) Yang, B. V.;
O’Rouke, D.; Li, J. Synlett 1993, 195.
4.5.20. 2-[40-(tert-Butyldimethylsilyloxy)phenyl]ethanol
(Table 4, entry 3).23n (Eluted with n-hexane/EtOAcZ6:1,
colorless oil); 1H NMR (300 MHz, CDCl3) d 7.08–7.06 (m,
2H), 6.81–6.77 (m, 2H), 3.58 (t, JZ6.6 Hz, 2H), 2.80–2.76
(t, JZ6.6 Hz, 2H), 2.10 (s, 1H), 1.00 (s, 9H), 0.11 (s, 6H);
13C NMR (75 MHz, CDCl3) d 154.6, 131.5, 130.3, 120.5,
64.1, 38.8, 26.1, 18.6, K4.0.
9. (a) Davies, J. S.; Higginbotham, C. L.; Tremeer, E. J.; Brown,
C.; Treadgold, R. C. J. Chem. Soc., Perkin. Trans. 1 1992,
3043. (b) Cunico, R. F.; Bedell, L. J. Org. Chem. 1980, 45,
4797.
10. Determined from GC analysis using HP-5 column (Cross-
linked 5% PH ME Polysiloxane).
4.5.21. 2-[40-(tert-Butyldiphenylsilyloxy)phenyl]ethanol
(Table 4, entry 4).23o (Eluted with n-hexane/EtOAcZ6:1,
colorless oil); 1H NMR (300 MHz, CDCl3) d 7.73–7.70 (m,
4H), 7.41–7.33 (m, 6H), 6.94–6.91 (m, 2H), 6.72–6.69 (m,
2H), 3.77–3.71 (m, 2H), 2.74–2.68(m, 2H), 1.47(br, 1H), 1.09
(s, 9H); 13C NMR (75 MHz, CDCl3) d 154.6, 136.0, 133.4,
131.1, 130.3, 128.2, 126.3, 120.2, 64.1, 38.7, 27.0, 20.0.
11. We examined the selective TES cleavage over TBDMS with
lower amount of thionyl chloride (0.01, 0.02, 0.025 mol%),
and the results were still less desirable than those obtained with
1-chloroethyl chloroformate (83–89% yield vs 93–95%,
respectively).
12. Per suggestion from one of the reviewers, commercially
available 1.25 M HCl in methanol (Fluka) was examined in